Clinical trial
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment…
NCT00115154 · Graceway Pharmaceuticals, LLC, Industry · Completed
Key facts
| NCT number | NCT00115154 |
|---|---|
| Title | Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands |
| Official title | Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities |
| Lead sponsor | Graceway Pharmaceuticals, LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Keratosis |
| Intervention type | Drug |
| Interventions | Aldara (imiquimod) cream, 5% |
| Enrollment | 270 |
| Start date | May 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Jun 22, 2005 |
| Last update posted | Feb 19, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: